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The role of antibodies in protecting the host from human immunodeﬁciency virus type
1 (HIV-1) infection is of considerable interest, particularly because the RV144 trial results
suggest that antibodies contribute to protection. Although infection of non-human primates
with simian immunodeﬁciency virus (SIV) is commonly used as an animal model of HIV-1
infection, the viral epitopes that elicit potent and broad neutralizing antibodies to SIV have
not been identiﬁed. We isolated a monoclonal antibody (MAb) B404 that potently and
broadly neutralizes various SIV strains. B404 targets a conformational epitope comprising
the V3 and V4 loops of Env that intensely exposed when Env binds CD4. B404-resistant
variants were obtained by passaging viruses in the presence of increasing concentration of
B404 in PM1/CCR5 cells. Genetic analysis revealed that the Q733stop mutation, which
truncates the cytoplasmic tail of gp41, was the ﬁrst major substitution in Env during
passage. The maximal inhibition by B404 and other MAbs were signiﬁcantly decreased
against a recombinant virus with a gp41 truncation comparedwith the parental SIVmac316.
This indicates that the gp41 truncationwas associatedwith resistance to antibody-mediated
neutralization. The infectivities of the recombinant virus with the gp41 truncation were
7,900-, 1,000-, and 140-fold higher than those of SIVmac316 in PM1, PM1/CCR5, and
TZM-bl cells, respectively. Immunoblotting analysis revealed that the gp41 truncation
enhanced the incorporation of Env into virions. The effect of the gp41 truncation on
infectivity was not obvious in the HSC-F macaque cell line, although the resistance of
viruses harboring the gp41 truncation to neutralization was maintained. These results
suggest that viruses with a truncated gp41 cytoplasmic tail were selected by increased
infectivity in human cells and by acquiring resistance to neutralizing antibody.
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INTRODUCTION
The RV144 trial demonstrated 31% vaccine efﬁcacy for preventing
human immunodeﬁciency virus type 1 (HIV-1) infection (Rerks-
Ngarm et al., 2009). Antibodies against the HIV-1, particularly
against the V1/V2 loops, correlate inversely with infection risk
(Haynes et al., 2012). Further recent isolation of monoclonal anti-
bodies (MAbs) that neutralize a broad range of HIV-1 strains
suggest the possibility for developing a vaccine that can induce
cross-neutralizing antibodies effective for various HIV-1 strains
(Kwong and Mascola, 2012). Although non-human primate mod-
els of simian immunodeﬁciency virus (SIV) infection can facilitate
the evaluation of immunogens, epitopes and immune correlates,
no potent and broad neutralizing MAb against SIV had been
available.
To understand the mechanisms involved in neutralization
of infectivity by antibodies in an SIV model, we recently iso-
lated MAb B404 from a SIVsmH635FC-infected rhesus macaque,
which potently and broadly neutralizes various SIV strains,
such as SIVsmE543-3, SIVsmE660 and the neutralization-
resistant variants, genetically diverse SIVmac316, and highly
neutralization-resistant SIVmac239 (Kuwata et al., 2011). The
B404 epitope, which comprises the V3 and V4 loops of Env and is
intensely exposed by ligation of Env toCD4, is the target for potent
and broad neutralization of SIV (Kuwata et al., 2013). Vigorous
induction of B404-like neutralizing antibodies using the speciﬁc
VH3 genewith a long complementarity-determining region 3 loop
and λ light chain was observed in four SIVsmH635FC-infected
macaques. The B404-resistant variants were induced by passag-
ing viruses in the presence of increasing concentrations of B404.
Genetical analysis of the gp120 region of B404-resistant variants
revealed that themutations in theC2 region of Envwere important
for the resistance to antibody-mediated neutralization (Kuwata
et al., 2013).
In the present study, we further analyzed B404-resistant vari-
ants and determined the precise region responsible for the
resistance to antibody-mediated neutralization. Genetic analysis
of viruses during passage in the presence of B404 as well as pheno-
typic analysis using recombinant viruses revealed that a truncation
of the gp41 cytoplasmic tail was the primary step leading to escape
from neutralization.
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MATERIALS AND METHODS
CELLS
PM1 (Lusso et al., 1995), PM1/CCR5 (Yusa et al., 2005), and
HSC-F (Akari et al., 1999) cells were maintained in Roswell Park
Memorial Institute (RPMI) 1640 medium containing 10% fetal
bovine serum (FBS). TZM-bl (Platt et al., 1998; Derdeyn et al.,
2000; Wei et al., 2002; Takeuchi et al., 2008) and 293T (DuBridge
et al., 1987) cells were maintained in Dulbecco’s modiﬁed Eagle’s
medium containing 10% FBS.
GENETIC ANALYSIS OF B404-RESISTANT VARIANTS
The induction of variants resistant to Fab-B404 (Kuwata et al.,
2011) from SIVmac316 (Mori et al., 1992) harboring full-length
gp41 was performed as described previously (Yoshimura et al.,
2006; Hatada et al., 2010; Kuwata et al., 2013). Brieﬂy, 5,000
TCID50 (50% tissue culture infectious dose) SIVmac316 was incu-
bated with 5 ng/ml Fab-B404 for 30 min at 37◦C. Then, 5 × 104
PM1/CCR5 cells were added to the virus–Fab mixture. After incu-
bation for 5 h, cells were washed with phosphate-buffered saline
(PBS) and resuspended in RPMI 1640 supplemented with 10%
FBS without Fab-B404. The culture supernatant was harvested 7
days later and used to infect fresh PM1/CCR5 cells for the next
round of culture in the presence of increasing concentrations of
Fab-B404. Proviral DNA samples were extracted from cells using
a QIAamp DNA Blood Mini Kit (QIAGEN, Hilden, Germany)
after 8, 17, 20, 23, and 26 passages as well as from P26C cells
obtained after 26 passages in the absence of Fab-B404. The gp120
region was ampliﬁed using Platinum Taq DNA Polymerase High
Fidelity (Invitrogen, Carlsbad, CA, USA) with primers SEnv-F
(5′-ATG GGA TGT CTT GGG AAT CAG C-3′) and SER1 (5′-
CCA AGA ACC CTA GCA CAA AGA CCC-3′). The whole env
gene was ampliﬁed with primers SRev-F (5′-GGT TTG GGA
ATA TGC TAT GAG-3′) and SEnv-R (5′-CCT ACT AAG TCA
TCA TCT T-3′). The polymerase chain reaction (PCR) products
were cloned using a TA cloning kit (Invitrogen), and subjected
to sequencing. Nucleotide sequences were aligned and analyzed
phylogenetically using Molecular Evolutionary Genetics Analysis
version 5 (MEGA5) (Tamura et al., 2011).
CONSTRUCTION OF INFECTIOUS MOLECULAR CLONES WITH THE Env
REGION FROM B404-RESISTANT VARIANTS
One of the clones from passage 26, P26B404 clone 26, was selected
for construction of recombinant viruses, because this clone had
mutations typical of the major population of P26B404 variants.
Infectious molecular clones SS, SN, and NS were generated by
replacing fragments SphI–SacI [nucleotides (nt) 6,446–9,226],
SphI–NheI (nt 6,446–8,742), and NheI–SacI (nt 8,742–9,226) with
the corresponding regions of SIVmac316, respectively. Mutants
F277V and N295S, which have point mutations at amino acid
residues 277 and 295 of Env, respectively, were constructed by
PCR mutagenesis using the SIVmac316 plasmid as template. The
changes from phenylalanine (TTC) to valine (GTC) in F277V and
asparagine (AAT) to serine (AGT) inN295Swere introduced using
primers F277VFw (5′-TTG GTT TGG CGT CAA TGG TAC TAG
GGC-3′), F277VRv (5′-GTA CCA TTG ACG CCA AAC CAA G-
3′),N295SFw (5′-GGCAATAGTAGTAGAACCATAATTAG-3′),
and N295SRv (5′-AAT TAT GGT TCT ACT ACT ATT GCC-3′).
Mutant and parental SIVmac316 plasmids were transfected into
293T cells using X-tremeGENE 9 DNA Transfection Reagent
(Roche Molecular Biochemicals, Mannheim, Germany). After 2
days, the supernatants containing viruses were ﬁltered (0.45 μm)
and stored at −80◦C.
ANALYSIS OF VIRAL INFECTIVITY
For determination of TCID50 in PM1 and PM1/CCR5 cells,
5 × 104 cells in 50 μl were inoculated with 50 μl serially diluted
virus stocks in a 96-well plate and cultured for 2 weeks. Virus
replication was judged by observation of cytopathic effects (CPE)
by light microscopy. The TCID50 in TZM-bl cells was determined
by measuring luciferase activities. Brieﬂy, 100 μl medium, 50 μl
serially diluted virus stock, and 50 μl 1 × 104 cells containing
37.5 μg/ml diethylaminoethyl (DEAE) dextran were added to the
wells of a 96-well plate. The plate was then incubated at 37◦C
for 2 days. After washing with PBS, cells were lysed with 30 μl
cell lysing buffer (Promega, Madison, WI, USA) for 15 min at
room temperature (RT) and then 10 μl of cell lysate was trans-
ferred to a 96-well white solid plate (Coster, Cambridge, MA,
USA). Luciferase activity was measured using a Centro XS3 LB960
microplate luminometer (Berthold Technologies, Bad Wildbad,
Germany) and a luciferase assay system (Promega). The TCID50
was calculated according to the formula of Reed and Muench
(1938).
Infectivity of viruses in PM1, PM1/CCR5, and HSC-F cells
was evaluated by detecting infected cells using ﬂow cytometry
as described previously (Kuwata et al., 2011). Brieﬂy, PM1 and
PM1/CCR5 cells were adjusted to 1 × 106 cells/ml and HSC-F
cells were adjusted to 5 × 106 cells/ml. Aliquots of 100 μl cells
per well in a 24-well plate were inoculated with 100 μl of diluted
virus stocks. After incubation for 6 h, 800 μl fresh medium was
added to wells. One-half of the cells in each well were collected
at 4, 7, and 10 days post-inoculation. Cells were washed with PBS
and ﬁxed with IC Fixation Buffer (eBioscience, San Diego, CA,
USA). After washing with Permeabilization Buffer (eBioscience)
twice, the cells were intracellularly stained with 4 μg/ml (50 μl)
anti-p27 Fab, B450 (Kuwata et al., 2011) by incubation for 20 min
at RT. The cells were then incubated with 50 μl anti-HA antibody
(1:200; 3F10, Roche Molecular Biochemicals) for 20 min at RT
followed by incubation with 50 μl of anti-rat-FITC (1:500; Santa
Cruz Biotechnology, Santa Cruz, CA, USA) for 20 min at RT. The
stained cells were analyzed using a FACSCalibur (BD Biosciences,
Franklin Lakes, NJ, USA). Frequencies of infected cells were deter-
mined by comparison with an uninfected control. Data analysis
was performed using FlowJo (TreeStar, San Carlos, CA, USA).
All infectivity experiments were performed at least twice and
the representative results are shown.
ANALYSIS OF NEUTRALIZING ACTIVITIES
The Fab clones B404 and K8, isolated from an SIV-infected
macaque (Kuwata et al., 2011), and murine MAb M318T (Mat-
sumi et al., 1995) were used to examine the sensitivity of viruses
to antibody-mediated neutralization in TZM-bl cells as described
previously (Kuwata et al., 2011). Brieﬂy, 100 μl serially diluted
antibodies in duplicate were incubated with 200 TCID50 (50 μl)
of virus in a 96-well plate. After incubation for 1 h at 37◦C, 100 μl
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of 1 × 105 TZM-bl cells/ml containing 37.5 μg/ml DEAE dextran
were added. After incubation for 2 days, luciferase activities were
measured as described above for the analysis of viral infectivity.
The 50% inhibitory concentrations (IC50) andmaximal percent of
inhibition (MPI) were calculated from the average values by non-
linear regression using Prism5 (GraphPad Software, San Diego,
CA, USA).
Sensitivity to neutralization by B404 in macaque cells was
analyzed using HSC-F cells, a cynomolgus macaque cell line
immortalized by infection with Herpesvirus saimiri (Akari et al.,
1999). Fab-B404was serially diluted and 50μl aliquots weremixed
with 50 μl undiluted or 10-fold diluted virus in a 96-well plate.
After 1 h incubation at 37◦C, 2 × 105 cells in 100 μl were added
to each well and cultured for 1 day. The infected cells were washed
twice with PBS, resuspended in 200μl freshmedium, and cultured
in a new 96-well plate. Viral infection was examined 4 days post-
inoculation by intracellular staining of p27, as described above
for the analysis of viral infectivity. Infectivity was determined
in duplicate and the average value was used for the analysis of
neutralization.
All neutralizing assays were performed at least twice and the
representative results are shown.
WESTERN BLOTTING ANALYSIS OF VIRAL PROTEINS
Cells and supernatants were collected from six-well plate 2 days
after transfection of 293T cells with infectious molecular clones, as
previously described (Yuste et al., 2005). Supernatantswere ﬁltered
(0.45μm) and clariﬁed by centrifugation for 10 min at 3,000 rpm.
The clariﬁed supernatants were centrifuged at 13,200 rpm for
90 min at 4◦C, and the viral pellets were resuspended in 1 ml
PBS and centrifuged again. Pellets were then dissolved in 80 μl
sample buffer [62.5 mM Tris–HCl, pH 6.8, 2% sodium dodecyl
sulfate (SDS), 25% glycerol, 5% 2-mercaptoethanol, 0.01% bro-
mophenol blue]. Cells were washed with PBS and lysed in 300 μl
sample buffer. Samples of virions and cell lysates were boiled for
5 min, and the proteins were separated by SDS-polyacrylamide gel
electrophoresis using SuperSep Ace 5–20% (Wako Pure Chem-
ical Industries, Osaka, Japan). Proteins were transferred to an
Immun-Blot PVDF Membrane (Bio-Rad Laboratories, Hercules,
CA, USA). The membrane was blocked with 5% skim milk TBS-T
(Tris-buffered saline containing 0.1% Tween 20) for 1 h at RT, and
then washed three times with TBS-T. For the detection of gp120,
the membrane was incubated overnight at 4◦C with 1 μg/ml
M318T (Matsumi et al., 1995) in 5% skim milk TBS-T. After wash-
ing three times with TBS-T, the membrane was incubated with
anti-mouse immunoglobulin G (IgG) peroxidase (1:4,000, Santa
Cruz Biotechnology) for 1 h at RT. The membrane was washed
three times with TBS-T and once with TBS, and then TMB solu-
tion (KPL, Gaithersburg, MD, USA) was added to develop color.
Viral proteins gp41 and p26 were similarly examined using crude
supernatants from bacterial culture producing B408 and B450
(Kuwata et al., 2011), which were mixed with the same amount
of 5% skim milk TBS-T. The membrane was incubated with anti-
HA-HRP antibody (1:1,000; Roche Molecular Biochemicals) and
Chemi-Lumi One L (Nacalai Tesque, Kyoto, Japan), and viral pro-
teins were visualized using ImageQuant LAS 4000 (GE Healthcare,
Piscataway, NJ, USA)
RESULTS
EVOLUTION OF VIRUSES DURING PASSAGE UNDER THE PRESSURE OF
Fab-B404
To select for variants resistant to MAb B404, an antibody that tar-
gets a conformational epitope comprising the gp120 V3 and V4
loops, we passaged SIVmac316 that possesses a full-length gp41
in PM1/CCR5 cells in the presence of increasing concentrations
of Fab-B404. The virus recovered at passage 26 (P26B404) was
resistant to neutralization by B404 (V3/V4) and other antibodies,
MAbs K8 (CD4i) and M318T (V2), that target epitopes other than
that recognized by B404 (Kuwata et al., 2013). The region covering
thewhole env genewere ampliﬁed by PCR and cloned fromviruses
at passage 8, 17, 20, 23, and 26. The nucleotide sequences were
phylogenetically analyzed to show the evolution of B404-resistant
variants (Figure 1). The ﬁrst major mutation was a change from
glutamine (CAG) to a stop codon (TAG) at 733rd amino acid
residue of Env. The Q733stop substitution in the gp41 cytoplas-
mic domain was observed in 12 of 14 clones at passage 8 and in all
clones thereafter. Another stop codon (W782stop) was the second
FIGURE 1 | Evolution of B404-resistant variants. Nucleotide sequences
of the env gene, which were derived from proviruses at passages 8, 17, 20,
23, and 26, were phylogenetically analyzed using MEGA5. Arrows indicate
major substitutions as follows: Q733stop,W782stop, V17L, and E176K.
Clones with representative amino acid substitutions were separated into
groups, which are shown on the right side along with the corresponding
substitutions.
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major mutation, which was detected after 17 passages. Substitu-
tionsV17L in the signal peptide and E176K in theV2 loop emerged
after 20 and 23 passages, respectively, although the E176K substi-
tution was also observed in P26C, control viruses after 26 passages
in the absence of B404 (Table 1). In addition to these substitu-
tions, most of clones acquired the F277V substitution in the late
stage of evolution, except for one group at passage 26 which has
the N295S substitution (see Figure 1, group 26II). Group 26II was
clearly distinguished from group 26I by amino acid substitutions,
such as T136M, N295S, and D571M/E (Table 1), suggesting two
lineages of variants in P26B404.
These results demonstrated that the ﬁrst step in acquiring resis-
tance to B404 was the truncation of gp41. Although substitutions
Table 1 | Frequency* of amino acid substitutions in Env clones from
B404-resistant variants after 26 passages.
Substitution Region P26B404 P26C
I II
gp120 (n = 22) (n = 8) (n = 14)
V17L Signal peptide 100% 100% 0.0%
G62S C1 0.0% 0.0% 21.4%
M67V/L/T C1 4.5% 0.0% 21.4%
A68T C1 0.0% 0.0% 92.9%
T136M V1 4.5% 87.5% 0.0%
T137I V1 0.0% 0.0% 14.3%
K141E/R V1 0.0% 12.5% 7.1%
E176K V2 90.9% 12.5% 35.7%
F277V C2 100% 0.0% 0.0%
N295S C2 0.0% 100% 0.0%
Q341H V3 13.6% 12.5% 14.3%
D374N C3 0.0% 0.0% 28.6%
K403R V4 0.0% 12.5% 7.1%
W441R C4 4.5% 0.0% 7.1%
gp41 (n = 10) (n = 2) (n = 7)
F528S/L Extracellular 20.0% 0.0% 0.0%
D571M/E Extracellular 10.0% 100% 0.0%
Q733stop Cytoplasmic 100% 100% 0.0%
W762stop Cytoplasmic 100% 0.0% 0.0%
W782stop Cytoplasmic 100% 0.0% 0.0%
A833T Cytoplasmic 90.0% 0.0% 0.0%
R839K Cytoplasmic 0.0% 0.0% 57.1%
R861K Cytoplasmic 100% 100% 0.0%
*Percentages of substitutions in populations P26B404 and P26C, which were
obtained after 26 passages in the presence and absence of B404, respectively, are
shown.The P26B404 population is separated into two subpopulations according
to the phylogenetic analysis in Figure 1. All the substitutions that are observed in
more than one clone are shown here. Boldface indicates substitutions dominant
(>50%) in each population. The numbers of clones analyzed for the gp120 and
gp41 regions are shown in parentheses.
in gp120, represented by F277V,might contribute to the resistance
to a high concentration of B404, 20 passages were required for the
emergence of these substitutions.
TRUNCATION OF gp41 CONFERRED RESISTANCE TO
ANTIBODY-MEDIATED NEUTRALIZATION
To analyze effect of substitutions in B404-resistant variants on
resistance to neutralization, recombinant viruses were constructed
(Figure 2). The env region of SIVmac316 was replaced by that
of P26B404 clone 26, which had substitutions typical to the
P26I group. The resultant molecular clones SS, SN, and NS had
substitutions in the entire env region, gp120 and gp41 from
P26B404I, respectively. SS and NS were predicted to have a trun-
cated gp41 with no other mutation in gp41, because the Q733stop
substitution was the ﬁrst substitution in gp41. Point mutants
with substitutions F277V and N295S, which were representa-
tive mutations at late passages, were also constructed by PCR
mutagenesis.
These mutant viruses were examined for their sensitivity to
neutralization by three MAbs B404 (V3/V4 conformational), K8
(CD4i), and M318T (V2). The neutralization of SS that con-
tain the entire env region from P26B404I was similar to those
of P26B404, indicating that the env region is responsible for the
FIGURE 2 | Construction of infectious SIV clones with B404-resistant
mutations.The open reading frames of the SIV genome are shown along
with the Env substitutions in the B404-resistant variant typical to P26B404I.
Full-length SIV clones were constructed from parental SIVmac316 by
replacing the env region with that of the B404-resistant variant (blue) using
SphI, NheI, and SacI sites. The resultant virus SS contains all of the Env
substitutions present in P26B404I. Viruses SN and NS contain substitutions
in gp120 and gp41, respectively. Point mutants F277V and N295S were
constructed by inserting the substitutions F277V and N295S into
SIVmac316, respectively.
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resistance to neutralization (Figure 3A). Recombinants SN and
NS, which have substitutions in gp120 and gp41 from P26B404I,
respectively, showed varying degrees of resistance. The IC50 val-
ues of SN and NS against B404 were intermediates between the
parental SIVmac316 and the neutralization-resistant P26B404.
Maximal inhibition reached a plateau at 73.8, 82.3, and 81.9%
in SS, NS, and P26B404, respectively, but the MPI value of SN
(94.9%) was close to that of SIVmac316 (100%; Figure 3B). Neu-
tralization resistance to anti-CD4i MAb K8 was characterized by
decreases in the IC50 value of SN and the MPI of NS. Neutraliza-
tion by anti-V2 MAb M318T was even enhanced in SN, although
NS showed the resistance comparable to those of SS and P26B404.
The decreases in MPI values were commonly observed for the
neutralization of NS by the three MAbs (Figure 3B). Resistance to
neutralization was not signiﬁcantly detected by the point mutants
F277V and N295S, except for the neutralization of F277V by K8
(4.3-fold decrease of IC50 value). These results indicated that the
entire env region, including substitutions in both gp120 and gp41,
was responsible for the full-resistance of P26B404 to neutraliza-
tion. The decrease of MPI values for NS suggested that truncation
of gp41 by the Q733stop substitution, the ﬁrst major substitution
in viral evolution, was important to escape from the neutralizing
antibodies.
INCREASED INFECTIVITY FOR HUMAN CELLS BY SIV WITH A
TRUNCATED gp41
Truncation of gp41 in SIV is associated with the adaptation to
human cells (Hirsch et al., 1989; Kodama et al., 1989), which may
partially contribute to neutralization resistance (Yuste et al., 2005).
To explore themechanismof neutralization resistance of P26B404,
the infectivity of recombinant viruseswas analyzed bydetermining
the TCID50 values of virus stocks prepared by transfection of 293T
cells (Table 2). TheTCID50 values in all the human cells testedwere
signiﬁcantly higher for SS andNS viruseswith truncated gp41 than
FIGURE 3 | Sensitivities of viruses with B404-resistant mutations to
neutralization by MAbs. (A) Sensitivities of mutant viruses SS, SN, and NS
to neutralization by MAbs Fab-B404 (anti-V3/V4), Fab-K8 (anti-CD4i), and
M318T (anti-V2) are shown. Neutralization of parental SIVmac316 and
B404-resistant P26B404 is also shown as controls sensitive and resistant to
neutralization, respectively. (B)The sensitivities to neutralization are
represented by values for IC50 (μg/ml) and MPI (%). Viruses were examined
for their sensitivities to neutralization by MAbs Fab-B404, Fab-K8, and M318T
in TZM-bl cells. The IC50 and MPI values were determined using Prism 5. The
fold-change of IC50 was calculated by dividing the IC50 value by that of the
parental SIVmac316. Percent change of MPI was calculated by subtracting
the MPI value from that of SIVmac316. These changes are shown in
parentheses and signiﬁcant changes are indicated by magenta (IC50: >10;
MPI: < −20) and orange (IC50: 3–10; MPI: −20 to −10) highlighting.
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parental SIVmac316 and SN, in which gp41 is intact. In particu-
lar, NS showed a striking increase in TCID50 values, which were
7,100-, 1,000-, and 140-fold higher than those of parental SIV-
mac316 inPM1, PM1/CCR5, andTZM-bl cells, respectively. These
results indicate that truncation of gp41 caused by the Q733stop
substitution increases viral infectivity for human cells.
To compare viral infectivity in human and macaque cells, viral
infectionwasmonitored after inoculation of PM1 and PM1/CCR5
human cells and the HSC-F cynomolgus macaque cell line with
varying dilutions of virus stocks (Figure 4). Consistent with the
TCID50 analysis, a higher frequency of infected cells was detected
earlier in PM1 and PM1/CCR5 cells inoculated with NS than the
parental SIVmac316. In contrast, SN showed decreased infectiv-
ity in PM1 and PM1/CCR5 cells, apparently because PM1 cells
were not infected by a 1,000-fold diluted SN stock. Although
the TCID50 values of SS were much higher than those of SIV-
mac316, the replication kinetics of SS were similar to those of
SIVmac316 in PM1 and PM1/CCR5 cells. These results suggest
Table 2 | Infectivity* of viruses with substitutions from P26B404.
Viruses PM1 PM1/CCR5 TZM-bl
SIVmac316 4.2E+02 (1.0) 1.4E+03 (1.0) 9.6E+04 (1.0)
SS 2.9E+05 (710) 4.7E+05 (350) 6.3E+06 (66)
SN 2.0E+03 (4.8) 8.4E+03 (6.2) 2.9E+05 (3.1)
NS 2.9E+06 (7,100) 1.4E+06 (1,000) 1.4E+07 (140)
*Infectivity is shown by theTCID50/ml values of the viruses, whichwere prepared
by transfection of 293T cells, in PM1, PM1/CCR5, and TZM-bl cells. The fold-
change, which was calculated by dividing the mutant TCID50/ml value by that of
the parental SIVmac316, is shown in the parentheses.
that gp41 truncation increases infectivity for human cells and that
the substitutions in gp120 of P26B404I are associated with slow
and poor replication compared with that of SIVmac316.
Infectivity for macaque cells was more signiﬁcantly affected
than that for humancells by the substitutions in gp120of P26B404I
(Figure 4, lower panels). Infected cells were detected in HSC-F
cells inoculated with 1,000-fold diluted virus stocks of SIVmac316
and NS, but viral infection in HSC-F cells was limited to a low
frequency even by inoculation with 10-fold diluted virus stocks of
SS and SN. Truncation of gp41 did not signiﬁcantly affect repli-
cation in HSC-F macaque cells, although truncation of gp41 was
disadvantageous for replication in primary T cell cultures from
macaques (Hirsch et al., 1989; Kodama et al., 1989).
These results demonstrate that gp41 truncation strikingly
increases infectivity for human cells, but not for macaque cells,
and that the substitutions in gp120 decrease infectivity in human
andmacaque cells. Truncation of gp41, which conferred extremely
high infectivity for PM1/CCR5 cells, may be the ﬁrst step to escape
from neutralization and the substitutions in gp120 may be the
second step to replicate in the presence of high concentration of
B404.
INCREASED INCORPORATION OF Env INTO VIRIONS IN SIV WITH
TRUNCATED gp41
Incorporation of Env into virions was examined using these
recombinant viruses, because increased infectivity by gp41 trunca-
tion was suggested to be associated with the Env content of virions
(Manrique et al., 2001; Zhu et al., 2003, 2006; Yuste et al., 2004,
2005). Analysis of viral proteins in cells and supernatants from
transfected 293T cells revealed that incorporation of Env into viri-
ons was signiﬁcantly high in SS and NS viruses with the Q733stop
substitution (Figure 5). MAb to gp120 showed a higher amount
FIGURE 4 | Replication of B404-resistant viruses in human and macaque
cells. Frequencies of infected cells at 4, 7, and 10 days post-infection are
shown. PM1 and PM1/CCR5 humanT cells and HSC-F cynomolgus macaque
T cells were infected with the various dilutions of SIVmac316, SS, SN, and
NS. Infected cells were detected using ﬂow cytometry after intracellular
staining by B450 (anti-p27 Fab).
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of gp120 and gp160 in virions from SS and NS than those from
SN and the parental SIVmac316, although the production of Env
proteins in the transfected cells was at the same level among all
the viruses (Figure 5A). MAb to gp41 also demonstrated that
truncated gp41 was more abundant in virions compared with
FIGURE 5 | Effect of B404-resistant mutations on the incorporation of
Env into virions. Cell lysates (left panels) and virions (right panels) of
SIVmac316 (lane 1), SS (lane 2), SN (lane 3), NS (lane 4), and mock-infected
control (lane 5), which were prepared from transfected 293T cells, were
analyzed byWestern blotting. Viral proteins gp120 (A), gp41 (B), and p27
(C) were detected using MAbs M318T (anti-gp120 V2), B408 (anti-gp41
cluster I), and B450 (anti-p27), respectively.
full-length gp41 (Figure 5B). Semi-quantiﬁcation by densitomet-
ric scanning of gp41 and p26 images suggested that the levels of
gp41 amount per virion in SS and NS were 12- and 44-fold higher
than that of SIVmac316, respectively, after adjusting virion num-
bers using the p26 amounts. In contrast to the increased amount of
Env proteins in virions from viruses with truncated gp41, the level
of Gag p27 in virions was low in SS and NS compared with those in
SN and SIVmac316 (Figure 5C). This indicates that the Env con-
tent per virion, which was normalized by the amount of p27, was
signiﬁcantly high in viruseswith truncated gp41. These results sug-
gest that truncationof gp41by theQ733stop substitution enhances
incorporation of Env into virions.
NEUTRALIZATION RESISTANCE OF SIV WITH TRUNCATED gp41 IN
MACAQUE CELLS
The analysis of infectivity of recombinant viruses suggested that
the resistance to neutralization by truncation of gp41might be due
to adaptation to human cells. To examine this hypothesis, sensitiv-
ity to neutralization by B404 was determined in HSC-F macaque
cells using SIVmac316 andNS,which showed similar infectivity for
HSC-F cells (Figure 4). In ﬂowcytometric analysis, infection in the
presence or absence of B404 demonstrated that the high sensitivity
of SIVmac316 and resistance of NS to neutralization were main-
tained in HSC-F cells (Figure 6). The frequency of infected cells
decreased from 41.5% to the background level (2.03%) in inocula-
tion with the undiluted stock of SIVmac316. In contrast, infection
with NS, even with a 10-fold diluted virus stock, was signiﬁcant in
HSC-F cells in the presence of B404 (Figure 6A). Neutralization
of NS in HSC-F cells was characterized by a decrease in maxi-
mal inhibition (Figure 6B), which was also observed in TZM-bl
cells (Figure 3A). The magnitude of resistance of NS to B404 was
greater when infection was performed using the undiluted stock
compared with the 10-fold diluted stock, raising the possibility
that B404 did not inhibit infection with a high titer of viruses.
However, the resistance of NS was shown by infection with a low
titer of NS, in which the frequency of infected cells in the absence
of B404 (23.8%) was lower than infection with undiluted SIV-
mac316 (41.5%). Further, immunoblotting analysis revealed that
the amount of virions was higher in the virus stock of SIVmac316
than that of NS (Figure 5).
These results indicate that gp41 truncation by the Q733stop
substitution contributes to neutralization resistance of viruses in
macaque cells. This suggests that the resistance to neutralization
by truncation of gp41 is not due to the adaptation to human
cells. The Q733stop substitution, the ﬁrst major mutation during
passages in the presence of B404, might be selected because it
facilitates adaptationof virus tohumancells and imparts resistance
to antibody.
DISCUSSION
In the present study, truncation of the cytoplasmic tail of gp41,
whichwas caused by theQ733stop substitution in Env,was the ﬁrst
major mutation detected during passage of SIV in the presence of
the neutralizing antibody B404. Analysis of recombinant viruses
suggested that the gp41 truncation was selected by their resistance
to neutralizing antibody, which was characterized by the decrease
of maximal inhibition comparedwith viruseswith intact gp41, and
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FIGURE 6 | Contribution of gp41 truncation to neutralization resistance
in infection of macaque cells. (A) Infection of HSC-F cells in the presence
(4 μg/ml) or absence of Fab-B404 is shown. HSC-F cells were inoculated with
undiluted SIVmac316 and NS, and 10-fold diluted NS. Viral infection was
monitored 4 days post-infection using ﬂow cytometry after intracellular
staining by B450 (anti-p27 Fab). (B) Neutralization of SIVmac316 and NS by
B404 in HSC-F cells are shown. Percent inhibition was calculated by
comparison with the infected culture in the absence of B404.
increased infectivity for human cells. The premature stop codon in
the gp41 cytoplasmic region was frequently detected in SIV strains
propagated in human cell culture in vitro, such as the original
SIVmac316 clone, SIVmac1A11 and 17E-Fr (Hirsch et al., 1989;
Kodama et al., 1989; Mori et al., 1992; Bonavia et al., 2005; Vzorov
et al., 2005). The truncation of gp41 is considered as an adaptation
of SIV to replication in human cell culture, because the premature
stop codon rapidly reverted to express full-length gp41 after infec-
tion of rhesus primary cell culture in vitro and rhesus macaques
in vivo (Hirsch et al., 1989; Kodama et al., 1989). Mutant viruses
harboring the gp41 truncation showed increased infectivity for
human cells, although the effects on infectivity varied depending
on the SIV strain and the length of the gp41 truncation (Man-
rique et al., 2001; Yuste et al., 2004, 2005;Vzorov et al., 2005, 2007).
The enhancement effect of gp41 truncation on incorporation of
Env into virions, which were demonstrated by quantiﬁcation of
viral proteins in virions (Yuste et al., 2004) and electron tomog-
raphy analysis of Env trimers on virions (Zhu et al., 2003, 2006),
was partly associated with the increased infectivity caused by gp41
truncation (Manrique et al., 2001;Yuste et al., 2004, 2005). Because
expression of Env on the cell surface is regulated by the cytoplas-
mic domain of gp41, truncation of gp41 may increase Env density
on both cells and virions (LaBranche et al., 1995; Berlioz-Torrent
et al., 1999; Postler and Desrosiers, 2013). Consistent with these
studies, infectivity for human cells and Env incorporation into
virions was enhanced by gp41 truncation in the present study.
Although the mechanism responsible for increasing viral infectiv-
ity caused by gp41 truncation remains unclear, the high virion Env
content may contribute to the efﬁcient replication of viruses with
truncated gp41 in human cells.
The effect of gp41 truncation on susceptibility to antibody-
mediated neutralization is controversial, perhaps due to the SIV
strainsused for the analyses. Becausemost of prototypic SIVclones
with truncated gp41 were macrophage-tropic, CD4-independent,
and neutralization-sensitive (Mori et al., 1992; Bonavia et al.,
2005; Vzorov et al., 2005), the truncation of gp41 was assumed
responsible for the high sensitivity to neutralization. However, the
resistance to neutralization by gp41 truncation was shown using
theE767stopmutant of SIVmac316 (Yuste et al., 2005). This is con-
sistent with our results using SIVmac316 harboring the Q733stop
substitution, indicating that gp41 truncation contributes to resis-
tance of SIVmac316 to neutralization. The increased infectivity
of viruses with gp41 truncation in human cells may partially
play a role in resistance by overcoming antibody-mediated neu-
tralization via efﬁcient attachment and entry of viruses to cells.
However, we showed that gp41 truncation was also associated
with neutralization resistance in macaque cells, in which gp41
truncation did not signiﬁcantly affect infectivity. This suggests
that the increased infectivity in human cells does not signiﬁcantly
affect the neutralization resistance of viruses with truncated gp41.
As shown by provision of excess Env in trans, high Env content
in virions may be critical for antibody-mediated neutralization
(Yuste et al., 2005). Further studies will be required to understand
the mechanism of resistance to neutralization conferred by gp41
truncation.
In the present study, we demonstrated that truncation of the
cytoplasmic tail of gp41 contributes to resistance to antibody-
mediated neutralization. Although non-human primate models
of SIV infection are commonly used to estimate vaccine efﬁcacy,
the lack of broadly neutralizing MAbs has hampered develop-
ment of antibody-based vaccine candidates in an SIV-macaque
model. The broadly neutralizing MAb B404, which neutralizes
multiple, diverse SIV isolates (Kuwata et al., 2013), is a useful tool
for understanding the mechanism of neutralization in an SIV-
macaque model and will contribute to the development of HIV-1
vaccines.
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